These results may be related to the fact that the type 2 diabetes mellitus (T2DM) prevalence did not significantly differ between the cohorts, and the patients from 2019 had a lower prevalence of coronary artery disease, history of stroke and higher average hemoglobin and albumin levels (see Table 1). This evidence concerns the gene ALB and diabetes mellitus.